Satish
☆    

India,
2015-07-15 10:35
(3590 d 09:17 ago)

Posting: # 15083
Views: 5,150
 

 90% CI of ratio of SDs for NTI drugs [RSABE / ABEL]

Dear all,

As we know for NTI drugs guidelines Warfarin has suggested that use both (1) scaled and unscaled ABE, in addition to that (2) calculation of 90% CI of ratio of within subject standard deviation of test to reference product.

here my problem is (2). i don't know how to calculate (2). but i tried it with 'COVPRMS' of 'PROC MIXED' from normal ln transformed data (not from ilat, dlat). i calculated within subject standard deviation for test and reference using 'estimates' in 'COVPRMS'. now i just want to know am i doing it in the correct way or not?

Thanks and Regards,
Satish.
khaledazeid
☆    

2016-12-31 13:57
(3055 d 04:56 ago)

@ Satish
Posting: # 16919
Views: 2,999
 

 90% CI of ratio of SDs for NTI drugs

Dear Satish
I have the same problem as you, so i hope you found a solution for it. If so please tell me
thanks in advance


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! [Helmut]
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
157 visitors (0 registered, 157 guests [including 38 identified bots]).
Forum time: 19:53 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5